Drug Type Synthetic peptide |
Synonyms TH 0318, TH0318, THGLP-1 |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC156H230N40O47 |
InChIKeyVDMZPQXIEINYMM-ZMYXDRBLSA-N |
CAS Registry676471-26-4 |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | - | 31 Aug 2004 | |
| Diabetes Mellitus, Type 2 | Phase 1 | - | 31 Aug 2004 |






